Bone TransplantationBone and BonesPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationStem CellsBone RemodelingTransplantation, AutologousHematopoietic Stem Cell MobilizationTransplantation, HomologousBone Marrow TransplantationHematopoietic Stem CellsBone DensityKidney TransplantationBone MarrowGraft SurvivalBone Marrow CellsCord Blood Stem Cell TransplantationBone ResorptionGranulocyte Colony-Stimulating FactorLeukapheresisStem Cell TransplantationTransplantsBone NeoplasmsTissue DonorsTransplantation ConditioningAntigens, CD34Graft vs Host DiseaseImmunosuppressive AgentsBlood Component RemovalBone DevelopmentGraft RejectionHematologic NeoplasmsBone DiseasesTreatment OutcomeMelphalanPlant StemsBone RegenerationCombined Modality TherapyHeart TransplantationTime FactorsCyclophosphamideTransplantationAdult Stem CellsRetrospective StudiesMultiple MyelomaBone MatrixNeoplastic Stem CellsBusulfanHistocompatibility TestingBlood CellsLung TransplantationHematopoiesisCyclosporineRecurrenceHistocompatibilityAntineoplastic Combined Chemotherapy ProtocolsFetal BloodWhole-Body IrradiationPluripotent Stem CellsBlood Cell CountTransplantation ChimeraCytomegalovirus InfectionsImmunosuppressionBone SubstitutesTacrolimusBone Diseases, MetabolicLeukemiaLymphoma, Non-HodgkinFractures, BoneBone Marrow DiseasesStem Cell NicheTissue and Organ ProcurementSurvival RateBone Morphogenetic ProteinsNeural Stem CellsFollow-Up StudiesAntineoplastic Agents, AlkylatingOsteogenesisInfectionMyeloablative AgonistsSurvival AnalysisBone Marrow PurgingEtoposideThiotepaTransplantation ImmunologyCell DifferentiationCells, CulturedMesenchymal Stem Cell TransplantationTransplantation, IsogeneicInduced Pluripotent Stem CellsMesenchymal Stromal CellsBone Morphogenetic Protein 2Postoperative ComplicationsStem Cell FactorCell LineageLiving DonorsRemission InductionMultipotent Stem CellsFlow CytometryImmunocompromised Host